1Akbari ME, Hosseini S J, Rezaee A, et al. Incidence of genitourinary cancers in the Islam- ic Republic of Iran: a survey in 2005 [ J ]. Asian Pac J Cancer Prey, 2008, 9 (4): 549 - 552.
2Babjuk M, Oosterlinek W, Sylvester R, et al. EAU guidelines on non - muscle - inva- sive urothelial carcinoma of the bladder [ J ]. European Urology, 2008, 54 (2): 303- 314.
3Jones JS, Campbell SC. Non - muscle - inva- sire bladder cancer (Ta, T1, and CIS ) [ J ]. Campbell - Walsh Urology, 2007, 9 : 2447 - 2467.
4Mufti GR, Singh M. Value of random mucosal biopsies in the management of superficial blad- der cancer [J]. Eur Urol, 1992, 22 (4): 288 - 293.
5Kriegmair M, Baumgartner R, Kntichel R, et al. Detection of early bladder cancer by 5 - aminolevulinic acid induced porphyrin fluores- cence [J]. JUrol, 1996, 155 (1): 109- 110.
6Berezney R, Coffey DS. Identification of a nuclear protein matrix [ J ]. Biochemical and Biophysical Research Communications, 1974, 60 (4) : 1410 - 1417.
7Cordon - Cardo G, Wartinger DD, Melamed MR, et al. Immunopathologic analysis of hu- man urinary bladder cancer. Characterization of two new antigens associated with low - grade superficial bladder tumors [J]. Am J Pathol, 1992, 140 (2): 375-385.
8Soloway MS, Briggman V, Carpinito GA, et al. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the uri- nary tract following surgical treatment [ J ]. J Urol, 1996, 156 (2 Pt 1) : 363 -367.
9Sarosdy MF, deVere White RW, Soloway MS, et al. Results of a multicenter trial u- sing the BTA test to monitor for and diagnose recurrent bladder cancer [ J ]. J Urol, 1995, 154 (2 Pt 1) : 383 -384.
10Parry WL, I-Iemstreet GP 3rd. Cancer detec- tion by quantitative fluorescence image analy-sis [J]. J Urol, 1988, 139 (2): 270- 274.
